Tablets-au.com Available ED Drugstore is an 1st. pharmacy providing a individual service to the society in Australia. Over 80,000 extremely satisfied buyers! We're your medication drug store levitra australia and have provided trusted service to families in Australia for over 15 years.

Slosman_publications.pdf

D.O. SLOSMAN, R. RIZZOLI, A. DONATH, J.-Ph. BONJOUR. Comparative study of the performances of X-ray and
gadolinium 153 bone densitometers at the level of the spine, femoral neck and femoral shaft. Eur J Nucl Med. 17:3-
9,1990.
T. CHEVALLEY, R. RIZZOLI, V. NYDEGGER, D.O. SLOSMAN, L. TKATCH, C.-H. RAPIN, H. VASEY, J.-Ph. BONJOUR.
Preferential low bone mineral density of the femoral neck in patients with a recent fracture of the proximal femur.
Osteoporos Int. 1:147-154,1991.
J.-Ph. BONJOUR, G. THEINTZ, B. BUCHS, D.O. SLOSMAN, R. RIZZOLI. Critical years and stages of puberty for spinal
and femoral bone mass accumulation during adolescence. J Clin Endocrinol Metab 73:555-563,1991.
P. AMMANN, R. RIZZOLI, D.O. SLOSMAN, J.-Ph. BONJOUR. Sequential and precise in vivo measurement of bone
mineral density in rats using dual-energy X-ray absorptiometry. J Bone Miner Res. 7:311-316,1992.
B. BUCHS, R. RIZZOLI, D.O. SLOSMAN, V. NYDEGGER, J.-Ph. BONJOUR. Bone mineral density of the lumbar spine,
the femoral neck and femoral diaphysis in a Genevan population sample. Scweiz Med Wschr. 122:1129-1136, 1992.
French.
G. THEINTZ, B. BUCHS, R. RIZZOLI, D.O. SLOSMAN, J.-Ph. BONJOUR. Longitudinal monitoring of bone mass
accumulation in healthy adolescents: evidence for a marked reduction after 16 years of age at the levels of lumbar spine
and femoral neck in female subjects. J Clin Endocrinol Metab. 75:1060-1065,1992.
L. TKATCH, C.-H. RAPIN, R. RIZZOLI, D.O. SLOSMAN, V. NYDEGGER, H. VASEY, J.-Ph. BONJOUR. Benefits of oral
protein supplement in elderly patients with fracture of the proximal femur. J Am Coll Nutr. 11:519-525,1992.
C. GABAY, P. RUEDIN, D.O. SLOSMAN, J.-Ph. BONJOUR, M. LESKI, R. RIZZOLI. Bone mineral density in patients with
end-stage renal failure. Am J Nephrol. 13:115-123,1993.
P. AMMANN, R. RIZZOLI, J. CAVERZASIO, T. SHIGEMATSU, D.O. SLOSMAN, J.-Ph. BONJOUR. Effects of the
bisphosphonate tiludronate on bone resorption, calcium balance, and bone mineral density. J Bone Miner Res. 8:1491-
1498,1993.
P. AMMANN, R. RIZZOLI, K. MÜLLER, D. SLOSMAN, J.-Ph. BONJOUR. IGF-1 and pamidronate increase bone mineral
density in ovariectomized adult rats. Am J Physiol. 265:E770-776,1993.
G. GEINOZ, C.-H. RAPIN, R. RIZZOLI, R. KRAEMER, B. BUCHS, D.O. SLOSMAN, J.P. MICHEL, J.-Ph. BONJOUR.
Relationship between bone mineral density and dietary intakes in elderly. Osteoporos Int. 3:242-248,1993.
J.-Ph. BONJOUR, G. THEINTZ, B. BUCHS, D.O. SLOSMAN, H. CLAVIEN, R. RIZZOLI. Variation in spinal femoral bone
mass gain, energy and calcium intake during adolescence. Osteoporos Int. 3 Suppl 1:67-68,1993.
P. RUEDIN, R. RIZZOLI, D.O. SLOSMAN, M. LESKI, J.-Ph. BONJOUR. Effects of oral calcitriol on bone mineral density in
patients with end-stage renal failure. Kidney Int. 45:245-252,1994.
D.O. SLOSMAN, R. RIZZOLI, C. PICHARD, A. DONATH, J.-Ph. BONJOUR. Longitudinal measurement of regional and
whole body bone mass in young healthy adults. Osteoporos Int. 4:185-190,1994.
J.-Ph. BONJOUR, G. THEINTZ, F. LAW, D.O. SLOSMAN, R. RIZZOLI. Peak bone mass. Osteoporos Int. 4 Suppl 1:7-
13,1994. Review.
T. CHEVALLEY, R. RIZZOLI, V. NYDEGGER, D.O. SLOSMAN, C.-H. RAPIN, J.-P. MICHEL, H. VASEY, J.-Ph.
BONJOUR. Effects of calcium supplements on femoral bone mineral density and vertebral fracture rate in vitamin-D-
replete elderly patients. Osteoporos Int. 4:245-252,1994.
P.-E. FOURNIER, R. RIZZOLI, D.O. SLOSMAN, B. BUCHS, J.-Ph. BONJOUR. Relative contribution of vertebral body and
posterior arch in female and male lumbar spine peak bone mass. Osteoporos Int. 4:264-272,1994.
R. RIZZOLI, T. CHEVALLEY, D.O. SLOSMAN, J.-Ph. BONJOUR. Sodium monofluorophosphate increases vertebral bone
mineral density in patients with corticosteroid-induced osteoporosis. Osteoporos Int. 5:39-46, 1995.
J. PEARSON and the European Quantitation of Osteoporosis Study Group (D.O. SLOSMAN, Geneva). European semi-
anthropomorphic spine phantom for the calibration of bone densitometers: assessment of precision, stability and accuracy.
Osteoporos Int. 5:174-184, 1995.
S. FERRARI, R. RIZZOLI, T. CHEVALLEY, D.O. SLOSMAN, J.A. EISMAN, J.- Ph. BONJOUR. Vitamin-D-receptor-gene
polymorphisms and change in lumbar-spine bone mineral density. Lancet. 345 :423-424,1995.
R. RIZZOLI, M. FORNI, M.A . SCHAAD, D.O. SLOSMAN, A.P. SAPPINO, J. GARCIA, J.-Ph. BONJOUR. Effects of oral
clodronate on bone mineral density in patients with relapsing breast cancer. Bone 18 :531-537,1996.
S.L. FERRARI, L.P. NICOD, J. HAMACHER, A. SPILIOPOULOS, D.O. SLOSMAN, T. ROCHAT, J.-Ph. BONJOUR, R.
RIZZOLI. Osteoporosis in patients undergoing lung transplantation. Eur Respir J. 9:2378-2382,1996.
P.-E. FOURNIER, R. RIZZOLI, D.O. SLOSMAN, G. THEINTZ, J.-Ph. BONJOUR. Asynchrony between the rates of
standing height gain and bone mass accumulation during puberty . Osteoporos Int. 7:525-532,1997.
J.-Ph. BONJOUR, A.-L. CARRIE, S. FERRARI, H. CLAVIEN, D.O. SLOSMAN, G. THEINTZ, R. RIZZOLI. Calcium-
enriched foods and bone mass growth in prepubertal girls : a randomized, double-blind, placebo-controlled trial. J Clin
Invest
. 15:1287-1294,1997.
S. FERRARI, R. RIZZOLI, D.O. SLOSMAN , J.-Ph. BONJOUR. Familial resemblance for bone mineral mass is expressed
before puberty. J Clin Endocrinol Metab. 83:358-361,1998.
S. FERRARI, R. RIZZOLI, D.O. SLOSMAN , J.-Ph. BONJOUR. Do dietary calcium and age explain the controversy
surrounding the relationship between bone mineral density and vitamin D receptor gene polymorphisms ? J Bone Miner
Res
. 13:363-370,1998.
M.A . SCHURCH, R. RIZZOLI, D.O. SLOSMAN, L. VADAS, P. VERGNAUD, J.-Ph. BONJOUR. Protein supplements
increase serum insulin-like growth factor-1 levels and attenuate proximal femoral bone loss in patients with recent hip
fracture. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 15:801-809,1998.
S. FERRARI, R. RIZZOLI, D. MANEN, D.O. SLOSMAN, J-Ph. BONJOUR. Vitamin D receptor gene start codon
polymorphisms (FokI) and bone mineral density: interaction with age, dietary, calcium and 3’-end region polymorphisms. J
bone Miner Res
. 13:925-930,1998.
D.O. SLOSMAN, D.M. PROVVEDINI, P.J. MEUNIER, P.D. DELMAS, M.-C. DE VERNEJOUL, Y. TSOUDEROS, J.Y.
REGINSTER. The use of different DXA brands in a multicentre clinical trial: consequences and limits. Journal of Clinical
Densitometry
. 2:37-44, 1999.
B. TROSSELLO, D.O. SLOSMAN, M. ROTH, B. UEBELHART, C. KIEKENS, A. CHANTRAINE, D. UEBELHART. Evolution prospective de la composition corporelle et des marqueurs biochimiques du remodelage osseux chez
l’hémiplégique. Ann Réadaptation Méd Phys. 42:151-160, 1999.
S.A. ZAMORA, R. RIZZOLI, D.C. BELLI, D.O. SLOSMAN, J.-Ph. BONJOUR. Vitamin D supplementation during infancy is
associated with higher bone mineral mass in prepubertal girls. J Clin Endocrinol Metab. 84:4541-4544; 1999.
S.P. NIELSEN, D.O. SLOSMAN, O.H. SORENSEN, B. BASSE- CATHALINAT, P. de CASSIN, C. ROUX, P.J. MEUNIER.
Influence of Strontium on bone mineral density and bone mineral content measurements by dual X-Ray absorptiometry.
Journal of Clinical Densitometry. 2:371-379, 1999.
A. TROMBETTI, M. W. GERBASE, A. SPILIOPOULOS, D.O. SLOSMAN, L.P. NICOD, R. RIZZOLI. Bone mineral density
in lung-transplant recipients before and after graft: prevention of lumbar spine post-transplantation-accelerated bone loss
by pamidronate. The Journal of Heart and Lung Transplantation. 19:736-743, 2000.
J.-Ph. BONJOUR, T. CHEVALLEY, P. AMMANN, D.O. SLOSMAN, R. RIZZOLI. Gain in bone mineral mass in prepubertal
girls 3-5 years after discontinuation of calcium supplementation: a follow-up study. Lancet. 358:1208-1212, 2001.
N. BUCHS, C. HELG, C. COLLAO, B. CHAPUIS, D.O. SLOSMAN, J-.Ph. BONJOUR, R. RIZZOLI. Allogeneic bone
marrow transplantation is associated with a preferential femoral neck bone loss. Osteoporos Int. 12:880-886, 2001.
G. GREMION, R. RIZZOLI, D.O. SLOSMAN, G. THEINTZ, J.P. BONJOUR. Oligo-amenorrheic long-distance runners may
lose more bone in spine than in femur. Med Sci Sports Exerc. 33:15-21, 2001.
D. HANS, R. RIZZOLI, D. THIEBAUD, K. LIPPUNER, S. ALLAOUA, L. GENTON, F. LUZUY, M.A. KRIEG, P. JAEGER,
D.O. SLOSMAN. Reference data in a swiss population: discordance in patient classification using T-scores between the
calcaneum, the spine and the femur. J Clin Densitom. 4:291-298, 2001
D. HANS, L. GENTON, M.K. DREZNER, A.M. SCHOTT, R. PACIFICI, L. AVIOLI, D.O. SLOSMAN, P.J. MEUNIER.
Monitored impact loading of the hip: initial testing of a home-use device. Calcif Tissue Int. 71:112-120, 2002
D. HANS, W. WACKER, L. GENTON, E. PARIS, C. LE-FLOCH, D.O. SLOSMAN. Longitudinal quality control methodology
for the quantitative ultrasound Achilles+ in clinical trial settings. Osteoporos Int. 13:788-795, 2002
D. HANS, S. ALLAOUA, L. GENTON, M. DELMI, H. VUAGNAT, R. RIZZOLI, S. TAHINTZI-ZAWADYNSKI, C. PERRON,
C. PICHARD, D.O. SLOSMAN. Is time since hip fracture influencing the discrimination between fractured and non
fractured subjects as assessed at the calcaneum by three technologically different quantitative ultrasound devices? Calcif
Tissue Int
. 71 :485-492, 2002
P.J. MEUNIER, D.O. SLOSMAN, P.D. DELMAS, J.L. SEBERT, M.L. BRANDI, C. ALBANESE, R. LORENC, S. PORS-
NIELSEN, M.C. DE VERNEJOUL, A. ROCES, J.Y. REGINSTER. Strontium ranelate: dose-dependent effects in
established postmenopausal vertebral osteoporosis – a 2-year randomized placebo controlled trial. J Clin Endrocrinol
Metab
. 87:2060-2066, 2002
Hans D, Alekxandrova I, Njeh C, Le-Floch C, Conicella G, Laugier P, SLOSMAN DO. Appropriateness of internal digital
phantoms for monitoring the stability of the UBIS 5000 quantitative ultrasound device in clinical trials. Osteoporos Int.
2005 Apr;16(4):435-45.

O. BRUYERE, C ROUX, J BADUNSKI, G ISAIA, MC de VERNEJOUL, J CANNATA, S ORTOLANI, D.O. SLOSMAN, J
DETILLEUX, JY REGINSTER. Relationship between change in femoral neck bone mineral density and hip fracture
incidence during treatment with strontium ranelate. Curr Med Res Opin 2007 23:3041-3045.
BRUYERE, C ROUX, J DETILLEUX, D.O. SLOSMAN, TD SPECTOR, P FARDELLONE, K BRIXEN, JP DEVOGEALER,
M DIAZ-CURIEL, C ALBANESE, JM KAUFMAN, S PORS-NIELSEN, JY REGINSTER. Relationship between bone minéral
density changes and fracture risk reduction in patients treated with strontium ranelate. J Clin Endocrinol Metab 2007
92:3076-3081.
C. KENDLER D.L., ADACHI J.D., JOSSE R.G., D.O. SLOSMAN. Monitoring strontium ranelate therapy in patients with
osteoporosis. Osteoporosis Int 2009. 7:1101-1106.
C. PICHARD, D. SLOSMAN, J-C. CHEVROLET, Ph. JOLLIET, U. KYLE. Interactions de la sous-nutrition et de la
renutrition sur le tissu musculaire. Nutr Clin Metab 6 : 209-218, 1992.
T. ROCHAT, D.O. SLOSMAN, C. PICHARD, D.C. BELLI. Body composition analysis by dual energy X-ray absorptiometry
in adults with cystic fibrosis. Chest 106 :800-805,1994.
C. PICHARD, U. KYLE, D.O. SLOSMAN, P. PENALOSA. Does fat-free mass as measured by bioelectrical impedance
permit estimation of energy expenditure in hospitalized anorexia nervosa patients ? Clin Nutr 15 :109-114, 1996.
C. PICHARD, Ph. JOLLIET, J.C. CHEVROLET, J.A. ROMAND, D.O. SLOSMAN. Recombinant human growth hormone in
chronic and acute respiratory insufficiency. Horm Res. 45:222-229,1996.
F. CURTIN, A. MORABIA, C. PICHARD, D.O. SLOSMAN. Body mass index compared to dual-energy X-ray
absorptiometry: evidence for a spectrum bias. J Clin Epidemiol. 50:837-843,1997.
C. PICHARD, U. KYLE, J.-P. JANSSENS, L. BURDET, T. ROCHAT, D.O. SLOSMAN, J.-W. FITTING, D. THIEBAUD, M.
ROULET, J.-M. TSCHOPP, M.- LANDRY, Y. SCHUTZ. Body composition by X-ray absorptiometry and bioelectrical
impedance in chronic respiratory insufficiency patients. Nutrition. 13:952-958,1997.
C. PICHARD, U.G: KYLE, G GREMION, G GERBASE, D.O. SLOSMAN. Body composition by X-ray absorptiometry and
bioelectrical impedance in female runners. Med Sci Sports Exerc. 29:1527-1534,1997.
C. PICHARD, P. SUDRE, V. KARSEGARD, S YERLY, D.O. SLOSMAN, V. DELLEY, L PERRIN, B HIRSCHEL. A
randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega-3 fatty
acids in HIV-infected patients. Swiss HIV Cohort Study. AIDS. 1:53-63,1998.
U.G. KYLE, C. PICHARD, D.O. SLOSMAN. Normal values for fat-free and fat mass in 1678 healthy adults measured by
bioelectrical impedance analysis (BIA). Clinical Nutrition. 17 Suppl. 1:49,1998.
U.G. KYLE, C. PICHARD, T. ROCHAT, D.O. SLOSMAN, J.-W. FITTING, D. THIEBAUD. New bioelectrical impedance
formula for patients with respiratory insufficiency : comparison to dual-energy X-ray absorptiometry. Eur Respir J. 12:960-
966, 1998.
A. MORABIA, A. ROSS, F. CURTIN, C. PICHARD, D.O. SLOSMAN. Relation of body mass index (BMI) to dual-energy X-
ray absorptiometry measure of fatness. Br J Nutrition. 82:49-55, 1999.
C. PICHARD, U.G. KYLE, D.O. SLOSMAN. Fat-free mass in chronic illness: comparison of bioelectrical impedance and
dual-energy X-Ray absorptiometry in 480 chronically ill and healthy subjects. Nutrition. 15:668-676, 1999.
104- C. PICHARD, U.G. KYLE, P.J. JOLLIET, D.O. SLOSMAN, T. ROCHAT, L. NICOD, J. ROMAND, N. MENSI, J.C.
CHEVROLET. Treatment of cachexia with recombinant growth hormone in a pre-lung transplantation patient: a case
report. Crit Care Med. 27:1639-1642, 1999.
C. PICHARD, U. G. KYLE, D. BRACCO, D. O. SLOSMAN, A. MORABIA, Y. SCHUTZ. Reference values of fat-free and fat
masses by bioelectrical impedance analysis in 3393 healthy subjects. Nutrition. 16:245-254, 2000.
U.G. KYLE, L. GENTON, L. KARSEGARD, D.O. SLOSMAN, C. PICHARD. Single prediction equation for bioelectrical
impedance analysis in adults ages 20-94 years. Nutrition 17:248-253, 2001.
U.G. KYLE, L. GENTON, D.O. SLOSMAN, C. PICHARD. Fat-free and fat mass percentiles in 5225 healthy subjects aged
15 to 98 years. Nutrition 17:534-541, 2001
U.G. KYLE, L. GENTON, D.O. SLOSMAN, C. PICHARD. Fat-free and fat mass percentiles in 5225 healthy subjects aged
15 to 98 years. Nutrition 17:534-541, 2001
U.G. KYLE, L. GENTON, D. HANS, L. KARSEGARD, D.O. SLOSMAN, C. PICHARD. Age-related differences in fat-free
mass, skeletal muscle, body cell mass and fat mass between 18 and 94 years. Eur J Clin Nutrition. 55:663-672, 2001
U.G. KYLE, A. MORABIA, D.O. SLOSMAN, N. MENSI, P.-F. UNGER, C. PICHARD. Contribution of body composition to
nutritional assessment at hospital admission in 995 patients: a controlled population study. Br J Nutrition. 86:725-731,
2001
U.G. KYLE, L. GENTON, D. HANS, V.L. KARSEGARD, J.-P. MICHEL, D.O. SLOSMAN, C. PICHARD. Total body mass,
fat mass, fat-free mass, and skeletal muscle in older people: cross-selectional differences in 60 year-old-persons. J Am
Geriatr Soc
. 49:1633-1640, 2001
U.G. KYLE, L. NICOD, J.A. ROMAND, D.O. SLOSMAN, A. SPILIOPOULOS, C. PICHARD. Four-year follow-up of body
composition in lung transplant patients. Transplantation. 75:821-828, 2003
U.G. KYLE, L. GENTON, G. MENTHA, L. NICOD, D.O. SLOSMAN, C. PICHARD. Reliable bioelectrical impedance
analysis estimate of fat-free mass in liver, lung, and heart transplant patient. Journal of Parenteral Nutrition. 2001 Mar-
Apr;25(2):45-51.
L. GENTON, D. HANS, U.G. KYLE, V.L. KARSEGARD, D.O. SLOSMAN, C. PICHARD. Half-body dual energy X-ray
absorptiometry (DXA) predicts whole body composition (WBC) in obese patients. Clin Nutr. 2003 Aug;22(S1):S22-3.
U.G. KYLE, C. HELG, R. RIZZOLI, D. HANS, D.O. SLOSMAN, C. PICHARD. Longitudinal follow-up of body composition
after bone marrow transplant (BMT). Clin Nutr. 2003 Aug;22(S1):S2-3.
U.G. KYLE, G. GREMION, L. GENTON. D.O. SLOSMAN, A. GOLAY, C. PICHARD. Physical activity and fat-free and fat
mass as measured ba bioelectrical impedance in 3853 adults. Med Sci Sports Exerc. Clin Nutr. 2004 Feb;23(1):79-88.
U.G. KYLE, G. L. GENTON. GREMION, D.O. SLOSMAN, C. PICHARD. Aging, physical activity and height-normalized
body composition parameters. Clin Nutr. 2004 Feb;23(1):79-88.
U.G. KYLE, G. L. GENTON, H.C. LUKASKI, Y.M. DUPERTUIS, D.O. SLOSMAN, D. HANS, C. PICHARD. Comparison of
fat-free mass and body fat in Swiss and American adults. Nutrition. 2005 Feb;21(2):161-9.

Source: http://www.osteoporosiscenter.ch/SLOSMAN_publications.pdf

Innovator duty of care in the pharmaceutical industry

Innovator duty of care in the pharmaceutical industryDoes the inventor or “innovator” of a brand-name drug have a duty of care to the consumers of that drug’s generic equivalent manufactured by a competitor? The Ontario Superior Court of Justice considered this question in the recent case of Goodridge v Pfizer Canada1 and determined that, for now, no such duty exists. In that decision, th

Microsoft word - calendarioa academico intro

NORMAS DE ORGANIZAÇÃO DO CALENDÁRIO DO ANO ACADÉMICO 2013 INTRODUÇÃO O calendário do ano académico é um dos instrumentos reguladores e estruturantes de todas actividades das Instituições de Ensino Superior (IES). O mesmo estabelece os períodos das acções de preparação do Ano Académico, a data de sua abertura, bem como define os períodos lectivos, as pausas e os p

Copyright © 2010-2014 Pdf Medical Search